NCT05152953Befejeződött
Preparing for Pharmacy-based Delivery of Long-acting Injectable Antiretroviral Therapy (LAI-ART)
Forrás: ClinicalTrials.gov · Utoljára frissítve: 2023. nov. 29.
Rövid összefoglaló (regiszter, angolul)
BACKGROUND: Long-acting injectable antiretroviral therapy (LAI-ART) is poised to revolutionize HIV treatment and prevention. Community pharmacies could serve as another place for people with HIV to get their ART injections. However, pharmacist and healthcare practitioner attitudes towards pharmacist administration of LAI-ART are understudied. Financial and human resources, pharmacist training, or changes in workflow have not been outlined. Little is known about whether patients will accept ART injections given in pharmacies. OBJECTIVE: The purpose of this project is to address the above knowledge gaps. The information generated can assist in the development of tools that can help scale community pharmacy-based delivery of LAI-ART. METHODS: Using a mixed-methods approach to better understand the pre-implementation environment, the study will employ electronic surveys and will administer semi-structured interviews via telephone for three key stakeholder groups: HIV clinic staff members, community pharmacists, and persons with HIV. Surveys will assess the appropriateness, acceptability, and feasibility of LAI-ART administration in community pharmacies. A semi-structured interview guide has been developed using constructs from the Consolidated Framework for Implementation Research (CFIR). Comparisons between and across stakeholder groups will be performed, looking for common themes as well as discrepancies.
- Állapot (regiszter)
- Befejeződött
- Vizsgálattípus
- Megfigyeléses
- Résztvevők száma
- 63 (tényleges)
- Első benyújtás
- 2021. nov. 29.
- Kezdés
- 2022. jún. 8.
- Elsődleges befejezés
- 2023. nov. 15.
- Fő szponzor
- University of California, San Francisco
- Betegségek
- HIV-fertőzés
- NCT-szám
- NCT05152953
Mit vállalsz
- Vizsgálat típusa: Megfigyeléses
- Bevont résztvevők: 63
- 2022. jún. 8. és az elsődleges befejezés (2023. nov. 15.) között
- 4 helyszín, 1 országban
- Vizitek és vizsgálatok: kérdezd a vizsgálat csapatát, a regiszter nem sorolja fel őket
A(z) ClinicalTrials.gov regisztermezőiből összeállítva. A vizsgálat felépítését írja le.
Ki nem vehet részt
Szó szerint a(z) ClinicalTrials.gov forrásból, témák szerint csoportosítva. Hogy ki vehet részt, azt csak a vizsgálat csapata dönti el.
Korábbi kezelés
- Pharmacy staff with no forseeable involvement in implementation of a long-acting injectable antiretroviral therapy administration program.
- Clinic staff members with no current or forseeable involvement in supporting patients to receive long-acting injectable antiretroviral therapies.
Más betegség
- Patients/persons who are not diagnosed with HIV, who are candidates for long-acting cabotegravir as HIV pre-exposure prophylaxis.
Egyéb
- Persons who do not speak English to a degree that would allow full comprehension of and participation in the study.
Kiket keres a vizsgálat
- Aged 18 years or over
- Access to telephone (at minimum), access to internet/email preferred
- Pharmacy staff members must meet the following additional criteria:
- Currently employed at a community (retail, independent, specialty, chain) or outpatient health system pharmacy.
- Self-reported likelihood or potential to be involved with some aspect (e.g. billing, scheduling, administering, advertising, training) of implementing long-acting injectable antiretroviral therapy in pharmacies.
- Patients (persons with HIV) must meet the following additional criteria:
- Self-reported diagnosis of HIV, currently taking antiretroviral therapy (LAI-ART or oral or other)
- Self-reported undetectable HIV-1 viral load (Note: if potential participant does not know they will be encouraged to contact their health care provider to ask)
- Access to telephone
- Clinic staff must meet the following additional criteria:
- Currently employed in a clinic practice where HIV-positive patients comprise > 10% of clinic population
- Self-reported likelihood or potential to be involved with some aspect (e.g. billing, scheduling, administering, advertising, training, referring patients to other clinics) of implementing long-acting injectable antiretroviral therapy in their own clinic setting.
Életkor a regiszterben: 18 év – - · Nem: nők és férfiak
Helyszínek (4)
Helyszínek a regiszter sorrendjében. Ha a profilodba mented a városodat, távolság szerint rendeződnek.
| Helyszín | Város | Ország | Helyszín állapota |
|---|---|---|---|
| Auburn University Harrison School of Pharmacy | Auburn | Egyesült Államok | Ismeretlen állapot |
| Nova Southeastern University College of Pharmacy | Fort Lauderdale | Egyesült Államok | Ismeretlen állapot |
| Texas A&M Irma Lerma Rangel College of Pharmacy | Kingsville | Egyesült Államok | Ismeretlen állapot |
| University of California San Francisco School of Pharmacy | San Francisco | Egyesült Államok | Ismeretlen állapot |
Ez az oldal tájékoztatás, nem orvosi tanács. Bármely vizsgálatról az orvosoddal beszélj.